|
|
| | SRT3025 Hydrochloride Basic information |
| Product Name: | SRT3025 Hydrochloride | | Synonyms: | SRT3025 Hydrochloride;SIRTUIN MODULATOR 1;SRT3025 HCL;Inhibitor,Sirtuin,Sirtuin modulator1,inhibit,Sirtuin modulator-1,Sirtuin modulator 1;5-(3-Methoxypropyl)-2-phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide hydrochloride | | CAS: | 2070015-26-6 | | MF: | C31H32ClN5O2S2 | | MW: | 606.2 | | EINECS: | | | Product Categories: | | | Mol File: | 2070015-26-6.mol |  |
| | SRT3025 Hydrochloride Chemical Properties |
| storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | DMSO:56.25(Max Conc. mg/mL);92.79(Max Conc. mM)
Ethanol:5.0(Max Conc. mg/mL);8.25(Max Conc. mM) | | form | A solid | | color | Light yellow to yellow |
| | SRT3025 Hydrochloride Usage And Synthesis |
| Uses | SRT3025 Hydrochloride is a SIRT1 activator which in turn inhibits RANKL-induced osteoclastogenesis in bone marrow-derived macrophages. Decreases osteoclast-mediated bone resporption. |
| | SRT3025 Hydrochloride Preparation Products And Raw materials |
|